To comply with the new law, the U.S. Department of Education recently issued a draft rule that would impose limits on how much graduate students can borrow — up to $20,500 per year and $100,000 in ...

SLNB, which involves surgical removal and analysis of a lymph node closest to the primary tumor, is the preferred method for axillary staging in early-stage breast cancer. However, accumulating ...

Combination regimens taken for a fixed duration can work as well as a continuous course of a single drug for initial treatment of chronic lymphocytic leukemia (CLL), according to research presented at ...

SAN ANTONIO – An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR ...

These results come on the heels of data presented at ASCO showing that another antibody-drug conjugate, Daiichi Sankyo and AstraZeneca’s Enhertu (fam-trastuzumab deruxtecan), improved progression-free ...

After three years of follow-up, most patients treated with Breyanzi remained in remission.

As federal and state funding for health programs shrinks, the Knight Cancer Institute at Oregon Health & Science University just hit the jackpot: A $2 billion donation from Nike cofounder Phil Knight, ...

ORLANDO — Targeted therapies and immunotherapies are increasingly offering viable alternatives to the chemotherapies that have stood for decades as a mainstay of treatment for individuals living with ...

The massive study found that hormonal contraception remains safe overall, but found small differences in breast cancer risk based on the hormones used in the formulation.

The Pan-Mass Challenge (PMC), the world’s single most successful athletic fundraiser, has announced a $78 million gift for cancer research, treatment and patient care at the top-ranked Dana-Farber ...

Large trial finds stereotactic radiation preserved quality of life but did not outperform standard course of radiation for disease-free survival.

The Food and Drug Administration (FDA) has granted marketing authorization for the first cryotherapy treatment for older women with early-stage, low-risk breast cancer. Cryoablation, which destroys ...